Acquisition of a High-Sensitivity Preclinical Quantitative microSPECT Imaging System

The National Institutes of Health (NIH) is seeking to acquire a high-sensitivity preclinical quantitative microSPECT imaging system. The system will be used to support quantitative biodistribution studies, radionuclide therapy development, treatment response monitoring, and absorbed dose calculations for preclinical cancer research. The new system must be compatible with standard DICOM image formats and support export of imaging data for downstream quantitative image analysis and dosimetry software platforms. Some key features of the required system include: • Rapid screening of novel radiopharmaceuticals • Dynamic biodistribution assessment • Longitudinal therapy monitoring • Imaging of emerging therapeutic radionuclides • Compatibility with standard DICOM image formats • Support for export of imaging data for downstream quantitative image analysis and dosimetry software platforms